2Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol, 2002,61(3): 215～229. 被引量：1
3Scholzen T ,Gerdes J, The Ki-67 protein: From the know ang unknoun. J cell Physiol, 2000,182(3):311～ 22. 被引量：1
4Neder L, Colli BO, Machado HR, et al. MIB-1 labeling index in astrocytic tumors-a clinicopathologic study.Clin Neuropathol, 2004,23(6):262～270. 被引量：1
5Prayson RA, Castilla EA, Hembury TA, et al. Interobserver variability in determining MIB-1 labeling indices in oligodendrogliomas. Ann Diagn Pathol, 2003,7(1): 9～13. 被引量：1
6KOMATA T,KANZAWA T,KONDO Y,et al.Telomerase as a therapeutic target for malignant gliomas[J].Oncogene,2002,21 (4):656 -663. 被引量：1
7MASUTOMI K,YU E Y,KHURTS S,et al.Telomerase maintains telomerestructure in normal human cell[J].Cell,2003,114(2):241 -253. 被引量：1
9KAYASELCUK F,ZORLUDEMIR S,GUMURDUHU D,et al.PCNA and Ki-67 in central nervous system tumors:correlation with the his tological ype and grade[J].Neurooncol,2002,57(2):115-121. 被引量：1
